Gingko Bioworks Acquires Gen9

News   Jan 23, 2017 | Original story from Gen9

 
Gingko Bioworks Acquires Gen9

Credit: Gingko Bioworks

 
 
 
 

RELATED ARTICLES

HIV Envelope Trimer Immunization Approach Optimized

News

Optimized immunizations reliably elicit protective antibodies in preclinical study, marking an important milestone on the way to an effective HIV vaccine.

READ MORE

BMS, QIAGEN Partner to Develop Gene Expression Profiles for Immuno-Oncology

News

QIAGEN and Bristol-Myers Squibb intend to develop GEPs for several Bristol-Myers Squibb I-O molecules under the initial agreement.

READ MORE

Boehringer Selects NOVA-EM for Their Global Environmental Monitoring Program

News

Boehringer Ingelheim plans to implement and validate the NOVA-EM (Environmental Monitoring) solution at multiple sites worldwide.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Genomics Research Informatics & Automation

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE